Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer.
- Published In:
- Pharmaceutics, 18(1) (2026)
- Authors:
- Zavvar, Taraneh Sadat, Santo, Giulia(2), Gruber, Leonhard, Kronthaler, Ariane, Hagenbuchner, Judith, Skvortsova, Ira, Piro, Inken, Steiger, Katja, Martinovic, Vladan, Minasch, Danijela, Löffler-Ragg, Judith, di Santo, Gianpaolo, Virgolini, Irene J, von Guggenberg, Elisabeth
- Database ID:
- RPEP-16534
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-16534APA
Zavvar, Taraneh Sadat; Santo, Giulia; Gruber, Leonhard; Kronthaler, Ariane; Hagenbuchner, Judith; Skvortsova, Ira; Piro, Inken; Steiger, Katja; Martinovic, Vladan; Minasch, Danijela; Löffler-Ragg, Judith; di Santo, Gianpaolo; Virgolini, Irene J; von Guggenberg, Elisabeth. (2026). Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer.. Pharmaceutics, 18(1). https://doi.org/10.3390/pharmaceutics18010138
MLA
Zavvar, Taraneh Sadat, et al. "Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer.." Pharmaceutics, 2026. https://doi.org/10.3390/pharmaceutics18010138
RethinkPeptides
RethinkPeptides Research Database. "Paving the Way for CCK2R-Targeted Peptide Receptor Radionucl..." RPEP-16534. Retrieved from https://rethinkpeptides.com/research/zavvar-2026-paving-the-way-for
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.